One Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.3M	Buy	22,368 +743	+3%	+$569K	0.47%	49
2025 Q4	$16.7M	Buy	21,625 +765	+4%	+$520K	0.5%	45
2025 Q3	$11.7M	Buy	20,860 +1,140	+6%	+$645K	0.37%	68
2025 Q2	$10.4M	Buy	19,720 +4,897	+33%	+$2.73M	0.36%	72
2025 Q1	$9.4M	Buy	14,823 +2,337	+19%	+$1.61M	0.32%	79
2024 Q4	$8.89M	Buy	12,486 +310	+3%	+$260K	0.29%	88
2024 Q3	$12.8M	Buy	12,176 +508	+4%	+$565K	0.41%	61
2024 Q2	$12.3M	Buy	11,668 +673	+6%	+$652K	0.42%	56
2024 Q1	$10.6M	Buy	10,995 +25	+0.2%	+$23.8K	0.38%	62
2023 Q4	$9.63M	Sell	10,970 -365	-3%	-$301K	0.38%	63
2023 Q3	$9.33M	Buy	11,335 +480	+4%	+$377K	0.41%	57
2023 Q2	$7.8M	Buy	10,855 +289	+3%	+$223K	0.35%	68
2023 Q1	$8.68M	Sell	10,566 -56	-0.5%	-$42.2K	0.43%	58
2022 Q4	$7.66M	Sell	10,622 -422	-4%	-$311K	0.41%	66
2022 Q3	$7.61M	Buy	11,044 +487	+5%	+$307K	0.45%	59
2022 Q2	$6.24M	Buy	10,557 +38	+0.4%	+$24.7K	0.37%	71
2022 Q1	$7.35M	Buy	10,519 +144	+1%	+$91.1K	0.39%	64
2021 Q4	$6.55M	Sell	10,375 -205	-2%	-$126K	0.5%	50
2021 Q3	$6.4M	Sell	10,580 -643	-6%	-$399K	0.53%	38
2021 Q2	$6.27M	Buy	11,223 +908	+9%	+$460K	0.56%	41
2021 Q1	$4.88M	Buy	10,315 +1,251	+14%	+$609K	0.54%	53
2020 Q4	$4.38M	Buy	9,064 +196	+2%	+$106K	0.53%	55
2020 Q3	$4.96M	Sell	8,868 -177	-2%	-$107K	0.68%	33
2020 Q2	$5.64M	Sell	9,045 -971	-10%	-$551K	0.81%	28
2020 Q1	$4.89M	Buy	10,016 +811	+9%	+$335K	0.83%	25
2019 Q4	$3.46M	Buy	+9,205	New	+$3.1M	0.53%	48